Jan 29 (Reuters) - Visioneering Technologies Inc (VTI) :
- PROVIDES CLINICAL RESEARCH UPDATE OF 141 CHILDREN WEARING NATURALVUE MULTIFOCAL
- DATA CONSISTENTLY SHOWS 90% DECREASE IN MYOPIC PROGRESSION REFRACTIVE ERROR IN 141 CHILDREN FOLLOWED FOR UP TO 4 YEARS
News: VTI Visioneering Technologies Provides Clinical Research Update Of Naturalvue Multifocal
Add to My Watchlist
What is My Watchlist?